Quantum Biopharma (QNTM) Divestments (2019 - 2024)

Quantum Biopharma has disclosed Divestments across 6 years of filings, most recently posting $2.7 million for Q4 2024.

• Divestments for Q4 2024 came in at $2.7 million, up 919.15% year-over-year; the trailing twelve-month figure through Dec 2024 was -$0.0 (up 100.0% YoY), and the FY2022 annual result was $12.7 million, changed N/A from the prior year.
• Divestments came in at $2.7 million for Q4 2024 at Quantum Biopharma, up from -$3.5 million in the prior quarter.
• In the past five years, Divestments ranged from a high of $4.3 million in Q1 2020 to a low of -$3.5 million in Q3 2024.
• The 5-year median for Divestments is $205488.4 (2023), against an average of $482301.7.
• Across the five-year window, Divestments jumped 1297.81% in 2020 and tumbled 1184.78% in 2024, its largest moves.
• Quantum Biopharma's Divestments stood at $141397.8 in 2020, then sank by 807.22% to -$1.0 million in 2021, then jumped by 89.34% to -$106586.0 in 2022, then jumped by 352.92% to $269579.0 in 2023, then surged by 919.15% to $2.7 million in 2024.
• The last three Divestments figures came in at $2.7 million (Q4 2024), -$3.5 million (Q3 2024), and $738222.0 (Q2 2024), per Business Quant data.